PT-141 is a cutting-edge cyclic melanocortin agonist that exhibits potential in the treatment of sexual dysfunction. This novel compound operates by enhancing specific receptors within the body, leading to enhanced sexual response. Preclinical studies have revealed that PT-141 has the potential to effectively treat a variety of sexual dysfunctions